Safety Training

If you can't find what you want, Ask Us.

Refine Your Results

reset

Filter by Category

Location

Dates

FEATURED VENDORS

Showing 1-20 of 367 results Sort by:

Courses

  • 1 Request Info

    Preparing for the FDA's Menu Labeling Regulations and Implementation Best Practices

    Recently Foyles restaurant in Glasbury-on-Wye has been fined £7,430 by Powys County Council for falsely describing the food offered on the restaurant's menus, website and social media. With the enforcement date fast approaching of May 2018, many such lawsuits are bound to happen. Restaurant chains, grocery store delis have until May 7, 2018 to put calorie counts on their menus. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/Preparing-for-the-FDA-s-Menu-Labeling-Regulations-and-Implementation-Best-Practices-502553/DECEMBER-2017-ES-TRAININGREGISTRY
  • 2 Request Info

    OSHA Fatal Four - Why Compliance with 'Regulations' Will Not Prevent a Workplace Fatality

    OSHA and the Bureau of Labor Statistics have recently published data on the rate of fatalities in the category known as the 'Focus Four', also referred to as the 'Fatal Four'. The Focus Four are: Fall protection, Electrocution, Struck-by and caught-in or -between. Anyone in the safety business will readily attest to the lethality of these categories. What the statistics have shown is that over the past five years, falls and electrocutions are being effectively controlled with the application of intensive training, personal protective equipment (PPE), improved protective measures, etc. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/OSHA-Fatal-Four-Why-Compliance-with-Regulations-Will-Not-Prevent-a-Workplace-Fatality-502510/DECEMBER-2017-ES-TRAININGREGISTRY
  • 3 Request Info

    Medical Device Software Risk Management Standard | Software Expert 2018

    Engineers are dedicated to making things work, so a focus on how they might fail and harm someone can seem alien. Managing risk, however, is essential for all medical products- medical devices, including those involving software, have produced some painful examples of poor risk management with serious consequences. Experience has shown that there is a better way, that it is possible to manage risk in a changing business and technical world. Regulatory bodies are placing increased emphasis on risk management, and technology shifts are introducing new sources of risk. Newer Lean-Agile methods are recognized by the FDA as a good way to accomplish risk management. Techniques for risk management are well established, but require specific interpretation when applied to software. keep enhancing: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901345SEMINAR?trainingregistry-January-2018-SEO
  • 4 Request Info

    Pharmaceutical Validation Guidelines | 21 CFR Part 11 Compliance 2018

    Computer Systems Validation (CSV) also known as Software Validation is all-pervasive in the Life Sciences Industry. It is a requirement of all the predicate rules, as well as 21 CFR 11 and Annex 11. However, unless one knows how to implement CSV, it is often very hard to detect the requirement for CSV, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the FDA has stepped up 21 CFR 11 inspections that include CSV. This course will build on the Validation and 21 CFR 11 Compliance Basic Course, to give hands on experience on executing on the computer systems validation of a system, and to discuss related activities such as Validation Master Plan, Infrastructure Qualification, Project Management for Validation and Validation of Test Tools keep enhancing: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901444SEMINAR?trainingregistry-January-2018-SEO
  • 5 Request Info

    Webinar on Prepaid Account Regulations: A Readiness Checklist

    This payments webinar will review the products covered by the regulation and the criteria used to determine coverage. Also very important to understand is the information that must be disclosed to the consumer at the time of purchase whether in a store, branch office, online or via phone and finally we will discuss Regulation E protection requirements. Our prepaid card webinar will conclude with the transaction history requirements and provide a deep-dive into the requirements for over-draft coverage and the conditions under which Regulation Z requirements must be followed. The payments webinar will finish with implementation of effective date requirements. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/PREPAID-ACCOUNT-REGULATIONS-A-READINESS-CHECKLIST-509967/NOVEMBER-2017-ES-TRAININGREGISTRY
  • 6 Request Info

    Webinar on How to Develop Clear, Concise, and OSHA-Compliant Procedures and Instructions

    Developing and implementing clear and concise safety procedures is the best way to ensure that employees safely perform their assigned tasks, reduce workplace injuries and illnesses, and meet OSHA regulatory requirements. This webinar will cover the basics of how to take potentially cumbersome written OSHA compliance policies and turn them into an employee user-friendly format. This will help with employee buy-in and engagement with safety and help to ensure OSHA compliance is maintained. Creating Job Safety Analysis/Job Hazard Analysis (JSA/JHA) can help supplement complicated OSHA written safety procedures. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://onlinecompliancepanel.com/webinar/HOW-TO-DEVELOP-CLEAR-CONCISE-AND-OSHA-503337/NOVEMBER-2017-ES-TRAININGREGISTRY
  • 7 Request Info

    FDA's Latest Regulations for Computer Systems Used in the Tobacco and Related Industries, Effective 08/08/2016

    The Tobacco Control Act went into effect by FDA on June 22, 2009. Through this ruling, the FDA regulated cigarettes, cigarette tobacco, roll-your-own tobacco and smokeless tobacco, but in 2016, the FDA finalized a rule, Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, which extends the FDA's authority to include the regulation of electronic nicotine delivery systems (such as e-cigarettes and vape pens), all cigars, hookah (water pipe) tobacco, pipe tobacco and nicotine gels, among others. The rule went into effect on August 8, 2016. This action is a milestone in consumer protection. Going forward, the FDA Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901294SEMINAR?trainingregistry-December-2017-SEO
  • 8 Request Info

    Applied Statistics for Scientists and Engineers 2017

    Throughout 21 CFR and guidance documents for the pharmaceutical, biopharmaceutical, and medical device industries, the application of statistical methods are specified for: setting validation criteria and specifications, performing measurement systems analysis (MSA), conducting stability analysis, using design of experiment (DOE) for process development and validation, developing process control charts, and determining process capability indices. Different statistical methods are required for each of these particular applications. Data and tolerance intervals are common tools used for setting acceptance criteria and specifications. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901138SEMINAR?trainingregistry-December-2017-SEO
  • 9 Request Info

    Why you Should be Worried about HIPAA 2017

    This seminar will be addressing how practice/business managers (or compliance offers) need to get their HIPAA house in order before the imminent audits or (even worse) litigation occurs against your organization under state laws of negligence. It will also address major changes under the Omnibus Rule and any other applicable updates for 2017. Areas covered will be texting, email, encryption, medical messaging, voice data and risk factors as they relate to IT. The primary goal is to ensure everyone is well educated on what is myth and what is reality with this law, there is so much misleading information all over regarding the do's and don'ts with HIPAA - I want to add clarity for compliance officers Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901048SEMINAR?trainingregistry-December-2017-SEO
  • 10 Request Info

    Quality by Design using Design of Experiments (QbD) 2017

    This seminar focuses on how to establish a systematic approach to pharmaceutical development that is defined by Quality-by-Design (QbD) principles using design of experiments (DOE). In addition, this course teaches the application of statistics for setting specifications, assessing measurement systems (assays), developing a control plan as part of a risk management strategy, and ensuring process control/capability. All concepts are taught within the product quality system framework defined by requirements in regulatory guidance documents. Using a QbD approach for pharmaceutical development studies should include a systematic understanding of the process and using this understanding to establish a control strategy as part of a comprehensive quality risk management program. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901134SEMINAR?trainingregistry-December-2017-SEO
  • 11 Request Info

    Auditing Analytical Laboratories for FDA Compliance 2017

    Auditing analytical laboratories can be complex because of the preparation that is often required. All of the GMP rules do not apply to the laboratory; while there may be additional requirements depending upon the type of testing that is being conducted. In many cases, the laboratory itself may not understand what regulations apply to the work that is being conducted. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901324SEMINAR?trainingregistry-November-2017-SEO
  • 12 Request Info

    Implementing ISO 13485:2016- 2017

    The final version of ISO 13485:2016 is now available and companies should be planning their implementation. There are significant changes from the earlier version; they will require major modifications to the Quality Management System (QMS). The new version has better alignment with FDA's QSR, but there are still major differences that create issues for effective QMS implementation. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901112SEMINAR?trainingregistry-November-2017-SEO
  • 13 Request Info

    Onsite GCP Review and Update including the all-important 'Investigators Responsibility' 2017

    Engineers are dedicated to making things work, so a focus on how they might fail and harm someone can seem alien. Managing risk, however, is essential for all medical products- medical devices, including those involving software, have produced some painful examples of poor risk management with serious consequences. Experience has shown that there is a better way, that it is possible to manage risk in a changing business and technical world. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901348SEMINAR?trainingregistry-November-2017-SEO
  • 14 Request Info

    The EU Clinical Trial Regulation + EU Filings & Registrations 2017

    This course covers the requirements for conducting Clinical Studies across the EU via the requirements of the EU Clinical Trial Directive and the impending changes coming to the EU through the EU Clinical Trial Regulation (for Drugs, Biologics & Combination Products). The course also covers recent updates on EU-GCP associated with the new regulatory framework, the highlights of the new EU Pharmacovigilance Directive, as it relates to studies and helpful tips into working with the European regulators. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901354SEMINAR?trainingregistry-November-2017-SEO
  • 15 Request Info

    Medical Device Registration and Approval Process for the Pacific Rim 2017

    Classification systems differ from that of the United States or European Union in select countries Medical devices are classified depending on their risk level Medical devices must also comply with additional country standards and these standards define industry-wide safety and performance requirements Regulatory registration process is defined for China, Hong Kong, India, Japan, South Korea, Taiwan, Singapore and Australia The regulatory process from product design to market entry for a new medical device or IVD is oftentimes complicated and unclear. In Asia Pacific, it can become difficult to make a clear distinction between your regulatory strategy and business strategy. And Much More... Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900990SEMINAR?trainingregistry-November-2017-SEO
  • 16 Request Info

    Webinar On OSHA's Hazard Materials Management & Chemical Safety

    This course will describe how to evaluate chemical hazards and develop controls to protect workers and the public from the hazard. Additionally, the webinar will discuss the need for OSHA training and present techniques for developing a safety plan that addresses the use of chemicals.Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/OSHAs-HAZARD-MATERIALS-MANAGEMENT-CHEMICAL-SAFETY-504927/AUGUST-2017-ES-TRAININGREGISTRY
  • 17 Request Info

    Webinar On GMP Auditing of Facilities Performing Cell-Based Methods

    Laboratories that perform cell-based methods must meet stringent GMP guidelines for analytical procedures. In addition, standard operating procedures that specifically address working with cells should be in place to maintain control of a live assay system. GMP inspections should cover additional topics in cell-based laboratories to confirm procedures are sound from a regulatory perspective.Price:$250.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/GMP-AUDITING-CELL-BASED-METHODS-506592/AUGUST-2017-ES-TRAININGREGISTRY
  • 18 Request Info

    Webinar On Implementing Effective Safety Audits

    Nobody at your facility has been hurt in more than a year. Weekly inspection forms are returned with no non-compliances. Are the facility's safety plans really working that well or is it just luck? Conducting a safety audit is one of the proven ways to answer that question.Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/IMPLEMENTING-EFFECTIVE-SAFETY-AUDITS-507553/AUGUST-2017-ES-TRAININGREGISTRY
  • 19 Request Info

    Complaints, Adverse Event Reporting, and Recalls - An Integrated Approach 2017

    Medical Device manufacturers operate in numerous regulatory systems that often have different requirements and are not always consistent. The new ISO 13485:2016 emphasizes this problem. Manufacturers must identify their roles, identify the regulatory requirements for that role, and incorporate them into the quality management system. The various jurisdictions, however, deal with post-market device issues in many different ways. The quality management system, QMS, needs three interlocking process: complaint management, adverse event reporting, and recalls. These processes also have supporting QMS processes such as corrective action and design changes. Overarching the QMS processes are the regulatory requirements, usually involving record keeping and reporting. This workshop covers these primary and secondary QMS processes and analyzes them in terms of US, EU, and Canadian regulations.
  • 20 Request Info

    Validation, Verification and Transfer of Analytical Methods from FDA/EMA, USP and ICH 2017

    Analytical methods and procedures should be validated to ensure reliability, consistency and accuracy of analytical data. Compendial methods should be verified to demonstrate the suitability of laboratories to successfully run the method and when methods are transferred between laboratories successful transfer should be demonstrated through testing. In case a laboratory wants to use an alternative method instead of a compendial method, equivalency of the alternative method to the compendial method should be demonstrated. Method validation recently got highest attention from regulatory agencies and industry task forces. For example, FDA and EMA released guidelines on method validation and transfer, and USP has proposed new approaches chapters for integrated validation, verification and transfer of analytical procedures, for equivalency testing and for statistical evaluation.